Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure' over safety concern
WORLD
October 13, 20201 min read291 words
Published: October 13, 2020  |  1 min read291 words
By , Lilly said earlier this month it was applying for emergency use authorization (EUA) for the antibody drug, LY-CoV555, for patients with mild to moderate COVID-19 based on data from another clinical trial.It is not uncommon to pause drug trials to investigate safety concerns,...
Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure' over safety concern Read more

No article scores yet.

There are no critic or public scores for this article yet.
critic reviews: 0
public reviews: 0
No reviews
img-trusted
100%
critic score
13 reviews
img-trusted
75%
public score
53 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
2 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
0 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
0 reviews

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.